Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-26 @ 3:02 AM
Study NCT ID:
NCT00632502
Status:
COMPLETED
Last Update Posted:
2019-01-02
First Post:
2008-02-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Neutrophilic Asthma Study With Navarixin (MK-7123, SCH 527123) (MK-7123-017)(COMPLETED)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-05-01
Start Date Type:
ACTUAL
Primary Completion Date:
2009-02-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-02-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-02-29
First Submit QC Date:
None
Study First Post Date:
2008-03-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-10-14
Results First Submit QC Date:
None
Results First Post Date:
2014-11-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-10
Last Update Post Date:
2019-01-02
Last Update Post Date Type:
ACTUAL